TAMs enhanced tumor growth of the subcutaneously injected luciferase tumor cells (CT26-luciferase) in NOD/SCID mice (Fig. 3a–c), while knockout of XBP1 in miTAMs inhibited tumor growth (Fig. 3d–f and Supplementary Fig. S4a–c). Here, DDX53 is linked to neoplasm.